Much evidence has been gathered in support of a critical role for p53 in the cellular response to DNA damage. p53 dysfunction is associated with progression and poor prognosis of many human cancers and with a high incidence of tumours in p53 knockout mice. The absence of a p53-dependent G 1 arrest that facilitates DNA repair or apoptosis might impact critically on clinical cancer in two ways. First, by abrogating the impact on therapy that operates via genotoxic damage and apoptosis; and second, by encouraging progression either by inducing genomic instability and DNA mis-repair or by permitting survival of mutants. However, experiments examining the relationship between p53 de®ciency and mutation frequency have so far failed to con®rm these predictions. The precise role played by p53 is therefore unclear. We now report use of a short term in vitro approach to assess the in¯uence of p53 on radiation-induced mutations at the hprt locus in murine B cell precursors that are normally radiation ultrasensitive. We ®nd a high number of hprt mutants among X-irradiated p53 null cells, which results from preferential survival as clonogenic mutants rather than from a p53-dependent increase in mutation rate. This result has important implications for genotoxic cancer therapy.
Introduction
p53 is a critical inducible regulator of the cellular response to DNA damage. It is functionally activated by DNA breaks and induces G 1 arrest via transcriptional regulation of the cyclin kinase inhibitor p21 WAF1 (Lane, 1992; Kastan et al., 1991; Kuerbitz et al., 1992; El-Deiry et al., 1994; Dulic et al., 1994) and possibly other targets. p53 mutations are frequently found in human cancer (Hollstein et al., 1991) especially in association with progression or high grade malignancy (Carder et al., 1993) . This is generally regarded as re¯ecting the importance, in the genesis of malignant clones, of by-passing the cell cycle constraints that facilitate repair or promote apoptosis (Levine et al., 1994) and so restrict the potential mutational impact of DNA damage. In line with this interpretation, mice de®cient in p53 by homologous recombination knockout are spontaneously highly susceptible both to leukaemia/lymphoma and solid tumours (Donehower et al., 1992; Purdie et al., 1994; Kemp et al., 1994) and progression of experimentally induced tumours is more rapid in the absence of p53 function (Kemp et al., 1993) . Additionally, p53
7/7 (null) ®broblast cell lines have a very high rate (100 ± 4506normal) of drug induced gene ampli®cation in vitro (Livingstone et al., 1992; Yin et al., 1992) and p53 7/7 bone marrow cells have an increased (*206) level of spontaneous stable chromosome abnormalities in vivo (Bouer et al., 1995) .
These observations suggest that p53 dysfunction not only promotes the spontaneous emergence of mutant cells and encourages progression of cancer but might restrict therapeutic ecacy since many cancer drugs and radiotherapy operate via the induction of DNA damage and p53-dependent apoptosis (Lowe et al., 1993a) . Clinically, the presence of p53 mutations in cancer cells is indeed associated with intransigence to treatment (reviewed in Harris and Hollstein, 1993; Imamura et al., 1994) and both in vivo studies with transplantable rodent tumours (Lowe et al., 1994) and in vitro studies with human cell lines (Fan et al., 1994) have demonstrated enhanced survival of p53 mutant or null cells in the face of normally lethal concentrations of cytotoxic drugs and ionizing radiation.
An important prediction that follows from these observations is that attempts to eradicate p53 7/7 clones by DNA-damaging agents could promote progression of disease by inducing mutations in cells that can avoid p53-dependent apoptosis signalling. This can be expected to occur irrespective of whether or not absence of p53 facilitates genomic stability and thereby increases mutation rate. In this paper we test this prediction directly by analysing the mutation frequency at the hprt locus in clonogenic pre-B cells from the bone marrow of p53 null animals. This cell type is normally ultrasensitive to apoptosis induced by DNA damage (Griths et al., 1994b) .
in short term survival assays (Clarke et al., 1993; Lowe et al., 1993b) . We have recently reported that murine IL7-dependent B cell precursors are ultrasensitive to apoptosis following ionizing radiation (X-rays, a particles from plutonium-238), DNA double strandbreaking drugs or corticosteroid (Griths et al., 1994a,b) . Sensitivity was associated with and dependent upon a lack of BCL-2 protein expression in these cells (Griths et al., 1994b) . It seemed likely, as with thymocytes (Clarke et al., 1993; Lowe et al., 1993a) and other cell types including myeloid progenitors (Lotem and Sachs, 1993; Blandino et al., 1995; Lee and Bernstein, 1993) and gastro-intestinal epithelial cells (Merritt et al., 1994; Clarke et al., 1994) , that ionizing radiation would induce apoptosis in B cell precursors via a p53-dependent pathway. We ®rst showed that Xradiation did indeed induce p53 protein in IL7-dependent B cell precursors from p53 wild type (+/+) or p53 heterozygous (+/7) mice but failed to do so in the same cell type derived from p53 null/homozygous (7/7) mice ( Figure 1 ). p53
7/7 B cell precursors were next assayed for radiation sensitivity. In accord with our earlier data (Griths et al., 1994b) , the total B cell precursor population from p53 +/+ mice was very susceptible to ionizing radiation-induced apoptosis in a short term (8 ± 24 h) survival assay ( Figure 2 ). Complete resistance up to maximum assayed dose of X-rays of 10 Gy was evident with p53 7/7 cells ( Figure 2a ). This marked enhancement in survival was accompanied by the anticipated decrease in apoptosis-associated DNA staining pro®les as analysed by¯ow cytometry ( Figure  2b ). Interestingly, p53 +/7 cells had some increased survival advantage over p53 +/+ cells ( Figure 2b ) as reported also for thymocytes heterozygous for p53 deletion (Clarke et al., 1993; Lowe et al., 1993b) .
Single cell/comet assay of the initial response of p53 +/7 and p53 7/7 cells to X-radiation-induced DNA damage
We next evaluated the response to p53 7/7 cells to Xirradiation at the single cell level by the single cell electrophoresis or comet assay (Ross et al., 1995) . This method provides the opportunity to analyse and quantify initial damage and repair. The results show that p53 7/7 cells and p53 +/+ cells incur an equivalent amount of DNA strand breakage per Gy of exposure and that this is subject to strandbreak repair within 1 h in both cell types (Figure 3a and b) . The DNA at p53 7/7 cells remains largely intact by this assay when analysed at either 1 or 4 h after exposure to 40 Gy (Figure 3a ), but in p53 +/+ cells, apoptotic DNA degradation is evident by 4 h in the form of a massive comet tail or nebula (Figure 3a and b) . These data suggest that p53 expression does not in¯uence the initial level of DNA damage induced by X-irradiation or the early repair process but, as observed in other assays (Figure 2 ), its absence prevents the intervention of an apoptotic response.
Although these eects of p53 on bulk DNA repair and survival after irradiation are clear, they do not necessarily imply long-term survival and sustained clonogenic capacity or ecient repair of all DNA damage, i.e. mutations induced by X-irradiation. We therefore investigated these two issues in additional experiments.
p53 expression and clonogenic survival after irradiation
After irradiation, B cell precursors of all genotypes had diminished clonogenicity, but the extent of this reduction was much less in p53 hprt mutant frequency in p53 7/7 cells following sublethal radiation
In the p53 null clonogenic cells surviving radiation (at up to 4 Gy), it is possible to examine directly the extent to which cells bearing DNA damage are propagated; Figure 1 Accumulation of nuclear p53 protein by B cell precursors after exposure to X-rays. B cell precursors from p53 +/+ , p53 +/+ or p53 7/7 mice were exposed to 3 Gy irradiation and after 3 h assessed for p53 nuclear staining by immuno¯uorescence. Controls are non-irradiated cells stained with same reagents cells that under normal circumstances would be deleted by apoptosis. We quanti®ed the incidence of functional loss mutations at the hypoxanthine phosphoribosyl transferase (hprt) locus following exposure of clono- Figure 2 X-irradiation induced apoptosis of B cell precursors is p53 dependent. Apoptosis of B cell precursors from p53 +/+ or p53 7/7 mice as detected by viability measurements (trypan blue exclusion) (a) and¯ow cytometry (b) 8 h after exposure to 3.0 Gy X-rays: (*) p53 +/+ , * p53 7/7 cells. Note that a subset (*25%) of p53 +/+ cells appears to be resistant in this short term (8 h) apoptosis assay (a); however, by 24 h the cell viability at 10 Gy was only 2.5% for p53
+/+ cells compared with 99% for p53
cells. In b cells have been stained for DNA content with propidium iodine. Fraction 3 is S+G 2 /M; fraction 2 represents cells in G 1 and fraction 1 is the sub-G 1 peak of apoptotic cells. The number given with each pro®le is the ratio of apoptotic/G 1 cells genic IL7-dependent B cell precursors to graded doses of X-rays and culture in the presence of 6-thioguanine (TG). In the absence of any X-radiation, clonogenic B cell precursors from p53 7/7 mice appeared to have a high (*2610
75
) hprt mutation frequency although this could not be estimated with accuracy because of the low cloning eciency of these non-transformed growth factor-dependent cells in primary culture. The frequency of hprt mutants in wild type cells could not be calculated but as we previously noted, this value is 53610 75 (Griths et al., 1994b) . Following radiation of wild type cells with 1 to 4 Gy, there were too few surviving clonogenic cells to estimate hprt mutation frequency. p53 7/7 cells exposed to X-radiation over a dose range that is normally lethal accumulate hprt mutations with an apparently high incidence and in a dose-dependent fashion with a maximum frequency of *7610
74 at 4 Gy ( Figure 5 ). We con®rmed that 6-TG-resistant colonies were hprt mutants by expanding a number of independent clones (from cultures irradiated at 4 Gy) in suspension culture in the presence of IL7. A total of 20 clones were analysed by Southern blot. Thirteen showed deletion of 3' sequences (exons 5 ± 9); 10 of these were re-probed for 5' sequences (exons 2 ± 4) and these were also deleted. These data accord with previous studies on +/+ and p53 7/7 sustain equal levels of initial damage, and exhibit similar repair kinetics over 3 h repair period. Only p53 +/+ cells were capable of subsequent DNA fragmentation by induction of apoptosis as a response to initial DNA damage. (b) DNA damage visualised following cell lysis, electrophoresis, staining with¯ourochrome, and epi¯uorescence. Both p53 +/+ and p53 7/7 cells sustain identical levels of DNA damage after 10 Gy irradiation, and exhibit pro®cient repair by 1 h. In p53 +/ + but not p53 7/7 B precursors initial DNA damage induces subsequent DNA fragmentation by 4 h a Figure 4 Impact of p53 on clonogenic survival of B cell precursors following X-irradiation. X-ray survival for bone marrow-derived colony-forming B cell precursors cultured from p53 +/+ ; p53 +/7 or p53 7/7 mice. Data given are the means+1 SEM from four, four and ®ve individual (+/+), (+/7) and (7/7) mice respectively. : P=0.00032
Figure 5 Induction of hprt mutations in B cell precursors from p53 7/7 mice after exposure to X-rays. 7 day B cell precursors from three p53 7/7 mice were pooled and exposed to X-rays in the presence of IL7 as described in Materials and methods. Symbols represent values from individual mice except^which is the mean value. The dose response was curvilinear on an arithmetic plot (of clonogenic mutant axis) but approximately linear when a log scale was used as shown. This pattern of dose response is similar to that reported before for hprt mutations induced by high dose rate of g or X-irradiation in mouse and human cells (Furono-Fukushi et al., 1993; Vijayalaxmi and Evans, 1984) and is attributed to hprt mutations arising by chromsome aberrations (Vijayalaxmi and Evans, 1984) b Radiation-induced mutation in p53 null cells SD Griffiths et al rodent cells which indicated that a large fraction of radiation-induced hprt gene mutants had lost all coding sequences (Breimer, 1988) . The frequency of hprt mutants following radiation might be an overestimate due to the overgrowth of dominant clones in the culture system. We therefore used immunoglobulin heavy (IGH) chain gene rearrangement patterns to provide insight into clonal origins, as previously shown using T cell receptor genes for analysis of mutant T cell clones arising in vivo (Nicklas et al., 1989) . Eight 6-TG-resistant colonies were picked and expanded in suspension culture with IL7 and clonal patterns of IGH rearrangement were analysed by Southern blot. Three clones had distinctive rearrangements but ®ve others had the same bi-allelic pattern of restriction fragments (data not shown). This suggests that whilst some mutant clones were probably sibling subclones, a signi®cant proportion were independent.
To relate the observed incidences of hprt mutation to absolute mutation frequencies, we developed an alternative clonal assay system that allowed us to identify individual clones in situ on bone marrow stromal cultures under limiting dilution conditions (see Materials and methods (Table 1) .
Discussion
These data demonstrate enhanced clonogenic survival of radiation ultrasensitive B cell precursors from p53 7/7 mice and the presence of induced mutants at the hprt locus within the survivors. We assume that Xirradiation at the doses used would induce hprt mutations in p53 +/+ cells also but these cells would be lost by apoptosis.
Although we have a calculated mutant frequency for p53 7/7 cells surviving 4 Gy, there were insucient surviving p53 +/+ B cells precursors to provide a comparative frequency. The issue then is whether an hprt mutant frequency of *7610 75 in p53 7/7 cells is the anticipated frequency irrespective of p53 status or is a high value re¯ecting hypermutation or genomic instability in the absence of p53 function. Previous studies on ionizing radiation and hprt mutant frequency have found an approximately linear relationship between log surviving fraction and mutant frequency (Thacker, 1979 (Thacker, , 1992 , irrespective of cells and mammalian species of origin. Similar mutant frequencies to that reported here following ionizing radiation have been reported by others using nonmalignant cells including Masson (1976), de Juijter and Simons (1980) and Vijayalaxmi and Evans (1984) . Superimposing our calculated hprt mutation rate in the fraction of cells surviving 4 Gy onto this earlier data (eg Figure 3 in Thacker, 1979) provides no support for the notion that p53 7/7 B cell precursors are hypermutable or have an increased mutation rate following radiation. We therefore conclude that despite the lack of data on p53 +/+ wild type mutant frequency, the clonogenic p53 7/7 cells surviving 4 Gy have an hprt mutant frequency that is probably in the normal range for this level of radiation exposure and that p53 de®ciency does not lead to hypermutability following DNA damage at least in this assay system. 7/7 mice) also reported normal frequencies for both spontaneous and genotoxic damage-induced mutants. However, there are several reasons why the bacterial lacI gene might not provide an appropriate read out: in particular large deletions (as found in the hprt gene) would probably be missed because of size constraints on the packaging into phage particles involved in the assay and deletion of the selection marker along with lacI would lead to an underestimation of mutants. These reservations are reinforced by the ®nding that an endogenous expressed gene Dlb-1 had a much higher level of X-ray-induced mutations (mostly involving large deletions) than a bacterial lacI transgene (Sands et al., 1995) . Our observations using hprt as a marker gene for deletion mutations contrasts with the high (100 ± 4506) spontaneous hypermutability of the hprt gene in colon cancer cells with genome instability or`replication error' phenotypes (Bhattacharyya et al., 1995; Eshleman et al., 1995) and may appear to be at odds with the earlier observations of very high rates (*10
74
) of ampli®cation in a drug-resistant gene in p53 7/7 cells (Yin et al., 1992; Bouer et al., 1995) . These observations are however based on very dissimilar experimental systems and may not in fact be discordant in their implications. Both Yin et al. (1992) and Livingstone et al. (1992) analysed clonogenic survivors in immortalized ®broblast p53 7/7 cell lines treated with the drug N-(phosphonacetyl)-l-aspartate (PALA) which inhibits de novo uridine synthesis. p53 7/7 cells that both survive PALA and retain clonogenity in its continued presence have ampli®ed copy number of the CAD gene which encodes the enzyme target for PALA. Failure of p53 7/7 cells to G 1 arrest in the presence of PALA may, as the authors suggest (Yin et al., 1992) , promote chromosome damage as cells progress through S phase under limiting supplies of dTTP. The result is therefore contingent upon insult and subsequent selection by the same agent (PALA). As implied by our experiments, it is the failure of p53-dependent apoptosis in p53 7/7 cells 1 2 3 C 1 2 3 C -gl 9.3kb -gl 6kb
IgH HPRT a b Figure 6 Clonal analysis and immunophenotyping of hprt mutants. (a) Clonal analysis of three hprt mutants: DNA from three individual clones was digested with EcoRI and subjected to Southern blotting. Immunoglobulin gene (IgH) rearrangements were detected using a J H region probe P5(J H ) (kind gift of George Yancopoulos; Nagasawa et al., 1994) . Note that three clones (lanes 1, 2 and 3) show distinctive bi-or mono-allelic rearrangements of the IgH gene. All three clones show deletions of the hprt gene (lanes 1, 2, 3) compared with control (C) DNA. Deletions of the hprt gene were detected using a cDNA probe corresponding to exons 5 ± 9 (pHPTS-ex59) (kind gift of Leslie Lock -see Lock et al., 1986) . C is a germline liver DNA control. The sizes of the germline ( that is the critical determinant of the outcome rather than genomic instability per se. Other published data are also very relevant to this issue. Lee et al. (1994) found a modest (26) excess of chromosomal damage (DNA double strand break associated micronuclei) in p53 7/7 cells following 2 ± 6 Gy g irradiation. Bouer et al. (1995) reported a 20-fold increase in spontaneous stable chromosome abnormalities by direct examination of bone marrow metaphases of p53 7/7 mice but found no overall increase in chromosome aberrations compared with p53 +/+ mice after exposure to 3 Gy of g-irradiation (Bouer et al., 1995) . The genetic lesions detected in all these experimental systems are dependent upon particular assay or detection systems and it is possible that some kind of genomic instability enhanced by radiation in p53 7/7 cells might be missed. For example, in our own assay, by using hprt, an X linked, single copy gene marker rather than an autosomal gene, we could have biased detection against some gross chromosomal loss mutants. Our data also suggested, albeit with very limited numbers, that the spontaneous hprt mutant frequency might be elevated (perhaps by up to 10 ± 206) in p53 7/7 cells. Collectively, these data suggest that although p53 7/7 cells may have an increased rate of spontaneous DNA aberrations, there is no evidence that absence of p53 function renders cells hypermutable in the face of genotoxic damage. However the major conclusion from our study is that lack of p53 function allows the survival and proliferation of mutants that otherwise would have been eliminated by apoptosis, and in this way is liable to engender new populations of altered cells, particularly after genotoxic injury. Our data also suggests that cells heterozygous for p53 loss are also of greater risk in this respect compared with wild type cells, although we did not measure mutant frequencies in this population. A necessary caveat of these studies is the use of a cell type that is normally ultrasensitive to radiation, i.e. lymphocyte precursors. We do not assume that a p53 7/7 phenotype would necessarily enhance clonogenic survival thereby promoting propagation of mutants in all cell populations including those that are normally more radiation-resistant.
Our ®ndings parallel those reported recently by Norimura et al. (1996) . These authors report that, following foetal irradiation (at 2 Gy), the total number of abortions and newborn malformations is the same in p53 7/7 versus p53 +/+ mice. However, in p53
background, 70% of embryos were malformed or mutant and less than 10% died in utero, whereas p53 +/7 embryos, 60% were aborted and only 20% were alive but malformed. Comparable experiments within our laboratories have yielded similar results (Clarke et al., in preparation) . The favoured interpretation is that absence of p53 function allows survival of cells (and hence embryos) mutated by irradiation that would otherwise be eliminated by apoptosis. This is essentially the same conclusion as in the present study, i.e. a p53 7/7 background is permissive for the survival of radiation-induced mutants.
We have used hprt as a convenient marker gene but assume that other genes, including some that are functionally relevant to cancer progression, could equally be targets for radiation-induced mutation and would be expressed in a p53 null background. This accords with the recent study of reduced latency of leukaemia/lymphoma development in p53 +/7 or p53 7/7 mice that are radiated with 1 to 4 Gy and with the selective advantage of p53 mutant clones in early stages of skin cancer (Ziegler et al., 1994) . These data then highlight a potential concern with current modalities of cancer therapy. Ionizing radiation and many drugs widely used in treatment operate by eliciting apoptosis (Lowe et al., 1993; Ziegler et al., 1994; Dive and Wyllie, 1993) . In view of the fact that many human leukaemias and cancers contain disabled p53 or other activated oncogenes such as BCL-2 (Walton et al., 1993) or BCR ± ABL (Kabarowski et al., 1994; Bedi et al., 1995) that eectively block apoptosis, clonogenic cells surviving such genotoxic treatment in vivo are likely to acquire mutations contributing to clonal progression of disease as a paradoxical consequence of abortive attempts to eradicate them. In these circumstances, higher doses of these therapeutic agents will decrease clonogenic survival but correspondingly increase the incidence of mutants within the surviving population. Abrogation of apoptosis in evolving cancer clones therefore provides a double hazard in the face of genotoxic therapy -intrinsic resistance and thereby a mutation penalty in survivors.
Materials and methods

Cell culture
Femoral bone marrow cells (2610 6 /ml) from 10 ± 12 week old male mice, in which the genetic background was a mixture of 129/Ola and BALB/c and where either one or both p53 alleles had been disrupted (Clarke et al., 1993) , were cultured for 7 days in the presence of supplemented McCoy's 5a medium (containing: pyruvate, MEM vitamins, sodium bicarbonate, essential and non-essential amino acids, 2-mercaptoethanol 5610 75 M and 15% FCS; Gibco) (Lee et al., 1989) plus recombinant human IL7 (800 U/ml; gift from Sano® Recherche, Labege, France and Sterling Winthrop Inc, Collegeville, PA) or, in some experiments, supernatant from an IL7-secreting cell line, J558L (Winkler et al., 1995) . After culture, the nonadherent cell viability was 498% by trypan blue exclusion and analysis by¯uorescence microscopy showed that 490% of cells expressed the B cell precursor markers B220, CD19 and BP-1 (Griths et al., 1994b) .
Detection of p53
Cytocentrifuge smears were prepared 3 h after X-ray exposure, ®xed in acetone/methanol (50/50%) and stained for p53 protein by indirect¯uorescence using a mouse p53 antibody speci®c for wild type/mutant epitopes (AB-1/Pab 421; Oncogene Science) and FITC-labelled goat anti-mouse IgG2a second layer. Controls consisted of mouse IgG2a immunoglobulin. Binding of p53 antibody was assessed bȳ uorescence microscopy.
Assay of apoptosis by¯ow cytometry
Seven day B cell precursors at a concentration of 1610 6 cells/ml were exposed to X-rays in the presence of IL7 as described in legend to Figure 1 . 1610 6 cells were ®xed in 70% ethanol for 8 h at 48C and resuspended in 1.0 ml PBS containing propidium iodide (20 mg/ml; Sigma) and RNAse (100 mg/ml; Sigma). After incubation for 30 min at 378C, cell cycle analysis was performed using a Becton Dickinson FACScan¯ow cytometry where the apoptotic cell fraction was detected in the red¯uorescent sub-G 1 (region 1) peak and cells with G 1 and S/G 2 M DNA contents were present in regions 2 and 3 respectively (Figure 2b) . The data are expressed as a ratio of the areas of sub-G 1 and G 1 DNA peaks.
X-irradiation
After 7 days of selection in IL7-containing culture medium, 1610 7 B precursor cells in 10 ml of supplemented McCoy's 5a medium containing IL7 were exposed to X-rays (1 ± 10 Gy) using a Pantak source at 0.95 ± 1.0 Gy/min. These cells were then either maintained in suspension at 1610 6 cells/ml culture for up to 24 h (for short term apoptosis assays) or cloned at 0.1 ± 2610 5 cells/ml in 1.0 ml of supplemented McCoy's 5a medium containing human IL7 (800 U/ml) and 0.3% agar in 35 mm petri dishes. Colonies were scored after incubation at 378C plus 7% CO 2 for 6 days. No colonies were obtained in the absence of IL7.
Detection of DNA damage, repair and apoptosis in single cells by the comet assay Initial DNA damage induction and the kinetics of repair were evaluated in B cell precursors from p53 +/+ or p53
mice using a neutral SCGE or`comet' assay, developed for the quanti®cation of DNA strand breaks (Ross et al., 1995) . Brie¯y, cells were irradiated on ice, then harvested immediately (no repair) or incubated at 378C for periods ranging from 15 min to 48 h. Cells were embedded in 1% low gelling temperature agarose (Sigma Type VII) at a ®nal concentration of 0.7% agarose, and pipetted onto fully frosted glass microscope slides (Dakin). Following the gelling of agarose on ice, cell lysis was undertaken using 0.5% SDS-30 mM EDTA and 0.25 mg/ml proteinase K pH 8.0 (Boehringer) at 48C for 1 h, followed by incubation in a waterbath at 378C overnight. Slides were rinsed in 0.56Tris-borate-EDTA before electrophoresis at 1 V/cm for 25 min in 0.5 TBE at 108C. Slides were stained with ethidium bromide (20 mg/ml) and visualized by epifluorescence using a Zeiss Axioskop microscope. Images were digitalised, and levels of induced DNA strand breakage quanti®ed as a comet moment (Kent et al., 1994) .
Detection of hprt mutants
For detecting hprt mutants after irradiation in the standard assays of IL7 expanded (day 7) B cell precursors, cells were cultured at 1 ± 2610 6 ml for a further 8 days in supplemented McCoy's 5a medium plus IL7 (800 U/ml) to allow for decline of endogenous hprt activity (Morley et al., 1983) . 5610 6 cells were cloned in 10.0 ml of supplemented McCoy's 5a medium plus IL7 (800 U/ml), and 0.3% agar, hprt mutants were selected with 6-thioguanine (TG) (2.5 mg/ml); this dose gave maximal inhibition of colony growth. The frequency of TGresistant colonies was calculated from the ratio of cloning eciencies in the presence and absence of 6-TG.
In some experiments, TG-resistant colonies induced by 4 Gy X-rays were picked o and replated in 1.0 ml of medium plus IL7 and TG. These colonies were expanded to 0.5 ± 1.0610 6 cells/ml and analysed for immunophenotype, hprt deletion or IgH gene rearrangement by Southern blotting.
Analysis of B cell precursor clonogenicity and mutation frequency in situ and at limiting dilution An alternative cloning assay was used in some experiments to enumerate independent hprt mutants arising after 4 Gy radiation. B cell precursors from bone marrow were expanded for 7 days in suspension culture with IL7 as previously described. Immediately after radiation at 4 Gy, the cells were plated onto a bone marrow stromal cell line PA6 (irradiated at 30 Gy) which supports B cell precursor proliferation (Winkler et al., 1995; Kodama et al., 1984) . Low dose (1 m/ml) IL7 was also added along with IL3 and concentrated supernatant from non-irradiated PA6 cultures (Nagasawa et al., 1994) . We had previously determined that under these conditions, wild type IL7-expanded B cell precursor cells would attach to the stromal cells, survive and form small colonies which could then either be expanded in situ by addition of optimal IL7 concentrations or killed by addition of 6-TG. Preliminary experiments were also required to evaluate the range and maximum number of colonies that could be scored per stromal culture (2 cm diameter well); this was up to 30 (i.e. beyond which there was con¯uence or merger of colonies). IL7-expanded p53 7/7 cells were plated in the following numbers: for non-irradiated cells, (to calculate cloning eciency) 10 3 per well; for 4 Gy irradiated cells to measure clonogenic survival, 10 4 cells per well; for 4 Gy irradiated cells to measure clonogenic survival in the presence of 6-TG, i.e. mutant colonies, 3 ± 5610 5 cells per well. All cultures were left for 8 days at 378C (the predetermined expression time for hprt in these cells (Griths et al., 1994a) ) and 6-TG then added to cultures plated with irradiated cells at 2 ± 5610 5 cells/ plate, representing a calculated 200 ± 400 CFC (surviving radiation) per culture. All cultures were then re-fed with the optimal proliferative concentration of IL7 (5% conditioned medium) plus IL3 (100 m/ml) and 10% PA6 cell supernatant. All cultures were scored for expanded, viable (4200 cells) colonies after 9 to 14 days. The frequency of p53 7/7 hprt mutant colonies following 4 Gy irradiation was assessed from the number of colonies in cultures with and without 6-TG.
